ENVELO NERVE CONFORMING GEL CONDUIT Trademark

Trademark Overview

On Tuesday, June 1, 2021, a trademark application was filed for ENVELO NERVE CONFORMING GEL CONDUIT with the United States Patent and Trademark Office. The USPTO has given the ENVELO NERVE CONFORMING GEL CONDUIT trademark a serial number of 90747359. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, April 2, 2024. This trademark is owned by Tulavi Therapeutics, Inc.. The ENVELO NERVE CONFORMING GEL CONDUIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, hydrogel for medical purposes
envelo nerve conforming gel conduit

General Information

Serial Number90747359
Word MarkENVELO NERVE CONFORMING GEL CONDUIT
Filing DateTuesday, June 1, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Goods and ServicesPharmaceuticals, namely, hydrogel for medical purposes
Translation of Words in MarkThe wording "ENVELO" has no meaning in a foreign language.
Disclaimer with Predetermined Text"NERVE CONFORMING GEL CONDUIT"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTulavi Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameTulavi Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 1 GRANTED
Tuesday, April 2, 2024SOU EXTENSION 1 FILED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, April 23, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, April 23, 2023FINAL REFUSAL E-MAILED
Sunday, April 23, 2023FINAL REFUSAL WRITTEN
Tuesday, April 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 9, 2022NON-FINAL ACTION E-MAILED
Sunday, October 9, 2022NON-FINAL ACTION WRITTEN
Thursday, August 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 17, 2022NON-FINAL ACTION E-MAILED
Thursday, February 17, 2022NON-FINAL ACTION WRITTEN
Tuesday, February 15, 2022ASSIGNED TO EXAMINER
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 4, 2021NEW APPLICATION ENTERED

Related Keywords

conduit conforming nerve envelo purposes medical hydrogel namely pharmaceuticals